2,284
Views
4
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation

, , , , , , , , & show all
Pages 422-432 | Received 24 Sep 2020, Accepted 02 Feb 2021, Published online: 19 Feb 2021

References

  • Azzi L, El-Alfy M, Labrie F. (2006). Gender differences and effects of sex steroids and dehydroepiandrosterone on androgen and oestrogen alpha receptors in mouse sebaceous glands. Br J Dermatol 154:21–7.
  • Azzi L, El-Alfy M, Martel C, Labrie F. (2005). Gender differences in mouse skin morphology and specific effects of sex steroids and dehydroepiandrosterone. J Invest Dermatol 124:22–7.
  • Balaji S, Wang X, King A, et al. (2017). Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling. Faseb J 31:868–81.
  • Bhattacharya SS, Garlapati VK, Banerjee R. (2011). Optimization of laccase production using response surface methodology coupled with differential evolution. N Biotechnol 28:31–9.
  • Bhattacharya SS, Syed K, Shann J, Yadav JS. (2013). A novel P450-initiated biphasic process for sustainable biodegradation of benzo[a]pyrene in soil under nutrient-sufficient conditions by the white rot fungus Phanerochaete chrysosporium. J Hazard Mater 261:675–83.
  • Bollyky PL, Bogdani M, Bollyky JB, et al. (2012). The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep 12:471–80.
  • Bollyky PL, Lord JD, Masewicz SA, et al. (2007). Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4 + CD25+ regulatory T cells. J Immunol 179:744–7.
  • Box GEP, Behnken DW. (1960). Some new three level designs for the study of quantitative variables. Technometrics 2:455–75.
  • Dao H, Kazin RA. (2007). Gender differences in skin: a review of the literature. Gend Med 4:308–28.
  • Day AJ, de la Motte CA. (2005). Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 26:637–43.
  • Edward M, Quinn JA, Pasonen-Seppänen SM, et al. (2010). 4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors. Br J Dermatol 162:1224–32.
  • Fraser JR, Laurent TC, Laurent UB. (1997). Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27–33.
  • Garantziotis S, Savani RC. (2019). Hyaluronan biology: a complex balancing act of structure, function, location and context. Matrix Biol 78-79:1–10.
  • Hanley K, Rassner U, Jiang Y, et al. (1996). Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone. J Clin Invest 97:2576–84.
  • Kakizaki I, Kojima K, Takagaki K, et al. (2004). A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279:33281–9.
  • Kessler SP, Obery DR, de la Motte C. (2015). Hyaluronan synthase 3 null mice exhibit decreased intestinal inflammation and tissue damage in the DSS-induced colitis model. Int J Cell Biol 2015:745237.
  • Kownatzki E. (2003). Hand hygiene and skin health. J Hosp Infect 55:239–45.
  • Kuipers HF, Nagy N, Ruppert SM, et al. (2016). The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice. Clin Exp Immunol 185:372–81.
  • Kultti A, Li X, Jiang P, et al. (2012). Therapeutic targeting of hyaluronan in the tumor stroma. Cancers 4:873–903.
  • Kwak S, Brief E, Langlais D, et al. (2012). Ethanol perturbs lipid organization in models of stratum corneum membranes: An investigation combining differential scanning calorimetry, infrared and (2)H NMR spectroscopy. Biochim Biophys Acta 1818:1410–9.
  • Malaisse J, Bourguignon V, De Vuyst E, et al. (2014). Hyaluronan metabolism in human keratinocytes and atopic dermatitis skin is driven by a balance of hyaluronan synthases 1 and 3. J Invest Dermatol 134:2174–82.
  • Meyer LJ, Russell SB, Russell JD, et al. (2000). Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 114:953–9.
  • Nagy N, Kuipers HF, Frymoyer AR, et al. (2015). 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol 6:123.
  • Papakonstantinou E, Roth M, Karakiulakis G. (2012). Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol 4:253–8.
  • Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45–45.
  • Plikus MV, Chuong CM. (2008). Complex hair cycle domain patterns and regenerative hair waves in living rodents. J Invest Dermatol 128:1071–80.
  • Sidgwick GP, Iqbal SA, Bayat A. (2013). Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin. Exp Dermatol 22:377–9.
  • Supp DM, Hahn JM, McFarland KL, Glaser K. (2014). Inhibition of hyaluronan synthase 2 reduces the abnormal migration rate of keloid keratinocytes. J Burn Care Res 35:84–92.
  • Tammi R, Pasonen-Seppänen S, Kolehmainen E, Tammi M. (2005). Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J Invest Dermatol 124:898–905.
  • Tammi R, Ripellino JA, Margolis RU, Tammi M. (1988). Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol 90:412–4.
  • Toole BP, Wight TN, Tammi MI. (2002). Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277:4593–6.
  • Yoshida H, Okada Y. (2019). Role of HYBID (hyaluronan binding protein involved in hyaluronan depolymerization), alias KIAA1199/CEMIP, in hyaluronan degradation in normal and photoaged skin. Int J Mol Sci 20: 5804–19.